Medidata Solutions Stock Rating Reaffirmed by Citigroup Inc. (MDSO)
Medidata Solutions (NASDAQ:MDSO)‘s stock had its “buy” rating restated by equities research analysts at Citigroup Inc. in a research note issued to investors on Wednesday, Analyst Ratings Network.com reports. They currently have a $53.00 target price on the stock. Citigroup Inc.’s price target would suggest a potential upside of 33.27% from the stock’s previous close.
Shares of Medidata Solutions (NASDAQ:MDSO) traded down 3.21% on Wednesday, hitting $39.77. 1,422,230 shares of the company’s stock traded hands. Medidata Solutions has a 52 week low of $29.025 and a 52 week high of $68.21. The stock has a 50-day moving average of $54.54 and a 200-day moving average of $57.18. The company has a market cap of $2.072 billion and a price-to-earnings ratio of 234.80.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.11 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.16 by $0.05. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $79.50 million. During the same quarter in the prior year, the company posted $0.18 earnings per share. The company’s quarterly revenue was up 21.0% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.75 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on MDSO. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $57.00 price target on the stock, down previously from $67.00. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $50.00 price target on the stock, down previously from $72.50. Finally, analysts at Needham & Company LLC cut their price target on shares of Medidata Solutions from $67.00 to $50.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Two analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Medidata Solutions has an average rating of “Buy” and an average target price of $59.95.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.